ADVB Advanced Biomed Inc. - Common Stock
$8,45
Precio · Ago 19, 2026
Fundamentales a fecha de May 15, 2026
Rango 52S
$0–$24
34% of range
Calificación del Analista
—
Precio Objetivo
—
P/E (TTM)
-2.6
ROE
-159.1%
Margen de Beneficio Neto
—
ADVB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$8.45
Capitalización Bursátil
$9M
P/E (TTM)
-2.6
BPA (TTM)
$-0.16
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-159.1%
Deuda/Capital
—
Rango 52S
$0 – $24
ADVB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-0.16
2024-06-30
→
2025-06-30
Flujo de caja libre
$-6M
2025-06-30
→
2025-06-30
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ADVB
Mediana de Pares
P/E (TTM)
-2.6
15.4
P/B (P/C)
2.6
1.6
Price / FCF (Precio / FCF)
-1.6
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ADVB
Mediana de Pares
ROA
-59.4%
-54.9%
ROE
-159.1%
-98.0%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ADVB
Mediana de Pares
Current Ratio (Ratio corriente)
2.1
4.7
Quick Ratio (Ratio Rápido)
1.0
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ADVB
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ADVB
Mediana de Pares
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ADVB | $15M | -4.4 | — | — | -159.1% | — |
| NSPR | $77M | -2.3 | 28.1% | -543.3% | -129.3% | 29.5% |
| RMTI | $33M | -5.5 | -31.8% | -7.7% | -15.8% | 16.9% |
| TELA | $53M | -1.4 | 15.8% | -48.4% | -501.1% | 67.7% |
| AIDX | — | — | 16.7% | -182.8% | -503.1% | 29.6% |
| NXGL | — | — | — | — | — | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 11
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $909.8K | · | |
| SG&A Expense | $2M | · | |
| Operating Expenses | $3M | · | |
| Interest Income | $24.9K | · | |
| Other Non-op | $-262.8K | · | |
| Pretax Income | $-3M | · | |
| Net Income | $-3M | · | |
| EPS (Basic) | $-0.16 | · | |
| EPS (Diluted) | $-0.16 | · | |
| Shares (Basic) | 20,525,699 | · | |
| Shares (Diluted) | 20,525,699 | · |
Balance general 19
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $3M | · | |
| Prepaid Expense | $2M | · | |
| Current Assets | $13M | · | |
| PP&E (Net) | $125.2K | · | |
| PP&E (Gross) | $1M | · | |
| Accum. Depreciation | $1M | · | |
| Other Non-current Assets | $2.6K | · | |
| Total Assets | $14M | · | |
| Accounts Payable | $358.2K | · | |
| Accrued Liabilities | $575.8K | · | |
| Current Liabilities | $10M | · | |
| Capital Leases | $5.9K | · | |
| Total Liabilities | $10M | · | |
| Common Stock | $1.1K | · | |
| Retained Earnings | $-19M | · | |
| AOCI | $1M | · | |
| Stockholders' Equity | $3M | $619.0K | |
| Liabilities + Equity | $14M | · | |
| Shares Outstanding | 1,082,000 | 20,000,000 |
Flujo de Efectivo 7
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $343.8K | · | |
| Operating Cash Flow | $-6M | · | |
| CapEx | $31.6K | · | |
| Investing Cash Flow | $-31.6K | · | |
| Financing Cash Flow | $6M | · | |
| Net Change in Cash | $295.9K | · | |
| Free Cash Flow | $-6M | · |
Rentabilidad 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| ROA | -59.4% | · | |
| ROE | -159.1% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.1 | · | |
| Quick Ratio | 1.0 | · |
Valoración (TTM) 8
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-3M | $-2M | |
| Market Cap | $15M | · | |
| P/E | -4.4 | · | |
| P/B | 4.4 | · | |
| P / Tangible Book | 4.4 | · | |
| P / Cash Flow | -2.6 | · | |
| P / FCF | -2.6 | · | |
| Earnings Yield | -22.9% | · |
Estado de resultados 11
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $243.2K | $186.3K | $236.0K | $265.2K | $220.0K | $212.4K | $181.7K | $209.1K | $313.5K | |
| SG&A Expense | $276.6K | $210.3K | $287.9K | $1M | $347.5K | $67.7K | $338.3K | $495.5K | $431.9K | |
| Operating Expenses | $519.8K | $396.6K | $523.9K | $1M | $567.5K | $280.1K | $520.0K | $704.6K | $745.4K | |
| Interest Income | · | $9.2K | $448 | $9.5K | · | $15.4K | $10 | $33.4K | $104 | |
| Other Non-op | $31.0K | $42.9K | $136.6K | $418.7K | $-630.0K | $-314.8K | $254.4K | $-138.2K | $-310.9K | |
| Pretax Income | $-488.9K | $7M | $-386.9K | $-1M | $-1M | $-579.5K | $-265.6K | $-809.4K | $-1M | |
| Net Income | $-488.9K | $7M | $-386.9K | $-701.6K | $-1M | $-907.9K | $-265.6K | $-809.4K | $-1M | |
| EPS (Basic) | $-0.38 | $0.31 | $-0.02 | $-0.03 | $-1.35 | $-0.05 | $-0.01 | $-0.04 | $-0.05 | |
| EPS (Diluted) | $-0.38 | $0.31 | $-0.02 | $-0.03 | $-1.35 | $-0.05 | $-0.01 | $-0.04 | $-0.05 | |
| Shares (Basic) | 1,284,923 | 21,640,000 | 21,640,000 | -39,953,402 | 1,023,955 | 20,000,000 | 20,000,000 | 0 | 20,000,000 | |
| Shares (Diluted) | 1,284,923 | 21,640,000 | 21,640,000 | -39,953,402 | 1,023,955 | 20,000,000 | 20,000,000 | 0 | 20,000,000 |
Balance general 20
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $3M | $3M | $3M | $5M | $3M | · | $3M | · | |
| Prepaid Expense | $8M | $8M | $3M | $3M | $3M | $481.7K | · | $443.1K | · | |
| Current Assets | $11M | $11M | $6M | $6M | $8M | $3M | · | $3M | · | |
| PP&E (Net) | $87.3K | $97.1K | $281.3K | $331.3K | $355.3K | $401.0K | · | $524.5K | · | |
| PP&E (Gross) | $1M | $1M | $2M | $2M | $2M | $2M | · | $2M | · | |
| Accum. Depreciation | $961.8K | $973.4K | $2M | $2M | $1M | $1M | · | $1M | · | |
| Intangibles | · | · | · | · | $20.3K | $50.5K | · | $119.0K | · | |
| Other Non-current Assets | $2.2K | $956 | $74.8K | $83.0K | · | · | · | · | · | |
| Total Assets | $11M | $11M | $6M | $7M | $8M | $5M | · | $4M | · | |
| Accounts Payable | $377.3K | $369.3K | $641.6K | $632.7K | $618.5K | $617.9K | · | $620.5K | · | |
| Accrued Liabilities | $238.5K | $224.0K | · | · | · | · | · | · | · | |
| Current Liabilities | $1M | $1M | $3M | $3M | $4M | $4M | · | $3M | · | |
| Capital Leases | $10.9K | $1.4K | $2.9K | $5.9K | $44.5K | $56.3K | · | $64.5K | · | |
| Total Liabilities | $1M | $1M | $3M | $3M | $4M | $4M | · | $3M | · | |
| Common Stock | $1.4K | $21.6K | $21.6K | $21.6K | $21.6K | $20.0K | · | $20.0K | · | |
| Retained Earnings | $-13M | $-13M | $-20M | $-19M | $-19M | $-17M | · | $-16M | · | |
| AOCI | $843.8K | $874.7K | $1M | $1M | $1M | $1M | · | $1M | · | |
| Stockholders' Equity | $9M | $9M | $3M | $3M | $4M | $619.0K | · | $2M | · | |
| Liabilities + Equity | $11M | $11M | $6M | $7M | $8M | $5M | · | $4M | · | |
| Shares Outstanding | 1,382,133 | 21,640,000 | 21,640,000 | 21,640,000 | 21,640,000 | 20,000,000 | · | 20,000,000 | · |
Flujo de Efectivo 8
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9.3K | $-12.9K | $48.0K | $64.4K | $78.1K | $-56.8K | $102.2K | $153.9K | $83.0K | |
| Amort. of Intangibles | · | · | · | · | $30.2K | $33.6K | · | · | $31.9K | |
| Operating Cash Flow | $-239.8K | $-513.6K | $-610.3K | $-2M | $-3M | $-841.8K | $-29.7K | $-475.8K | $-1M | |
| CapEx | $1.3K | $12.9K | $1.8K | $20.1K | $2.2K | $-10.7K | $20.0K | $53.3K | $-26.7K | |
| Investing Cash Flow | $-1.3K | $-12.9K | $-1.8K | $-20.1K | $-2.2K | $10.7K | $-20.0K | $-53.3K | $26.7K | |
| Financing Cash Flow | $268.3K | $315.5K | $447.5K | $-765.5K | $6M | $408.3K | $392.5K | $323.5K | $562.2K | |
| Net Change in Cash | $-2.0K | $-45.9K | $-247.4K | $-2M | $3M | $10.2K | $39.0K | $-55.7K | $-112.9K | |
| Free Cash Flow | · | · | $-612.1K | · | · | · | · | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -5.2% | 89.3% | -12.4% | · | -33.4% | · | · | · | · | |
| ROE | -7.3% | 135.8% | -25.8% | · | -67.0% | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | 8.6 | 1.9 | · | 1.9 | · | · | · | · | |
| Quick Ratio | · | 2.1 | 0.9 | · | 1.3 | · | · | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $5M | $4M | $-3M | · | $-4M | · | · | · | · | |
| Market Cap | $6M | $6M | $10M | · | $85M | · | · | · | · | |
| P/E | -3.2 | 1.7 | -3.0 | · | -21.8 | · | · | · | · | |
| P/B | 0.7 | 0.7 | 3.2 | · | 20.5 | · | · | · | · | |
| P / Tangible Book | 0.7 | 0.7 | 3.2 | · | 20.6 | · | · | · | · | |
| P / Cash Flow | · | · | -15.9 | · | · | · | · | · | · | |
| P / FCF | · | · | -15.8 | · | · | · | · | · | · | |
| Earnings Yield | -31.6% | 58.2% | -33.5% | · | -4.6% | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-06-30 | 2024-06-30 | |
|---|---|---|
| Beneficio neto | $-3M | $-3M |
| EPS Diluido | $-0.16 | $-0.14 |
Balance general
| 2025-06-30 | 2024-06-30 | |
|---|---|---|
| Ratio corriente | 2.1 | — |
| Ratio Rápido | 1.0 | — |
Flujo de Efectivo
| 2025-06-30 | 2024-06-30 | |
|---|---|---|
| Flujo de caja libre | $-6M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F)
Actividad institucional — Q4 2025 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 0 (-2 vs trimestre anterior) | 2 (+1 vs trimestre anterior) | 1 (-1 vs trimestre anterior) | 2 (+1 vs trimestre anterior) | -218K |
Comparado con Q3 2025. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.